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Abstract
The generation of DNA constructs is often a rate-limiting step in conducting biological experiments. Recombination cloning
of single DNA fragments using the Gateway system provided an advance over traditional restriction enzyme cloning due to
increases in efficiency and reliability. Here we introduce a series of entry clones and a destination vector for use in two,
three, and four fragment Gateway MultiSite recombination cloning whose advantages include increased flexibility and
versatility. In contrast to Gateway single-fragment cloning approaches where variations are typically incorporated into
model system-specific destination vectors, our Gateway MultiSite cloning strategy incorporates variations in easily
generated entry clones that are model system-independent. In particular, we present entry clones containing insertions of
GAL4, QF, UAS, QUAS, eGFP, and mCherry, among others, and demonstrate their in vivo functionality in Drosophila by using
them to generate expression clones including GAL4 and QF drivers for various trp ion channel family members, UAS and
QUAS excitatory and inhibitory light-gated ion channels, and QUAS red and green fluorescent synaptic vesicle markers. We
thus establish a starter toolkit of modular Gateway MultiSite entry clones potentially adaptable to any model system. An
inventory of entry clones and destination vectors for Gateway MultiSite cloning has also been established (www.
gatewaymultisite.org).
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Introduction
In the post-genomic era understanding gene function is a major
goal of biological research. Studies aimed at elucidating the
function of a gene often include determining its in vivo spatial and
temporal cell type-specific expression pattern, the effects of
silencing or ectopically expressing the gene, and the dynamic
subcellular localization and trafficking of its encoded protein. A
prerequisite for each of these analyses is usually the generation of a
novel DNA construct and this is typically a laborious, time-
consuming, multi-step process when using a traditional restriction
enzyme-based cloning approach. The development of recombi-
nation cloning utilizing phage lambda integrase [1] (marketed as
Gateway recombination cloning by Invitrogen) provided an
advance in efficiency and reliability for certain cloning applica-
tions, especially those that are highly repetitive. For instance,
cloning cDNAs for 1,282 Arabadopsis transcription factors into
yeast expression vectors [2], cloning cDNAs for 10,167 C.elegans
genes into E.coli expression vectors [3], and cloning .5000
Drosophila enhancers into GAL4 vectors [4].
A limitation of the original Gateway cloning technology
(hereafter single-fragment Gateway cloning) is that only one DNA
fragment at a time contained in an ‘‘entry’’ vector could be
recombination cloned into a ‘‘destination’’ vector to create an
expression clone. An advance in recombination cloning technology
was the development of multi-fragment recombination cloning that
allows simultaneous cloning of more than one DNA fragment into
an expression vector [5] (marketed as Gateway MultiSite recom-
binationcloningby Invitrogen). This multi-fragment recombination
cloning system utilizes mutant versions of the phage lambda
integrase recognition sequences that are only functional in specific
combinations. The current version of Gateway MultiSite recombi-
nation cloning allows flexible, simultaneous, position and orienta-
tion-specific cloning of two, three, or four DNA fragments into a
destination vector to create an expression clone.
Our intention in this work was to develop a starter toolkit
of entry clones suitable for Gateway MultiSite recombination
cloning. The entry clones we generated include insertions of
GAL4, QF, UAS, QUAS, eGFP, and mCherry DNA fragments.
We have also generated a Drosophila destination vector that was
used to demonstrate the functionality of these and numerous other
entry clones in vivo in Drosophila, but the entry clones are potentially
compatible with other model systems with an appropriate
destination vector. A website database of Gateway MultiSite entry
clones and destination vectors has also been established (www.
gatewaymultisite.org).
Results
Similar to Gateway single-fragment recombination cloning,
Gateway MultiSite recombination cloning is a two-step process. In
the first step, DNA fragments (typically PCR products) containing
flanking attB sites are recombination cloned via the BP reaction (a
recombination reaction between attB and attP sites) into pDONR
vectors containing attP sites to create ‘‘entry’’ clones. The entry
clones are then mixed in appropriate two, three, or four fragment
combinations with a ‘‘destination’’ vector in the LR reaction (a
recombination reaction between attL and attR sites) to generate
expression clones. A major difference between single-fragment
Gateway cloning and Gateway MultiSite cloning is the latter
utilizes six distinct pDONR vectors instead of one. These six
pDONR vectors are depicted in Figures S1A-F. Each pDONR
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sites provide substrate specificity and are converted into distinct
attL and attR sites in the BP reaction. A list of the attB sequences
used for generating Gateway MultiSite entry clones via the BP
reaction is shown in Table S1.
The second step of MultiSite recombination cloning involves
integrating the fragments contained in the entry clones into a
destination vector via the LR reaction. We decided to assess the
functionality of our Gateway MultiSite entry clones in Drosophila
and hence designed the fly destination vector pDESThaw for
compatibility with two, three, or four fragment Gateway MultiSite
recombination cloning. Our strategy in developing this toolkit was
to incorporate into the destination vector only features common to
all constructs including a polyadenylation sequence from the
hsp70 gene, an attB site from phage PhiC31 for site-specific
genome integration, and mini-white as a transformation marker
(Figure 1A). Unlike Gateway single-fragment cloning approaches
where variability is distributed between the entry clones and the
destination vectors, the strategy of our MultiSite toolkit involves
placing all the variability in modular entry clones. In the LR
reaction, the destination vector is combined with appropriate
combinations of entry clones and the distinct attL and attR sites
ensure position and orientation-specific insertion of the entry clone
fragments into the destination vector.
Two-fragment Gateway MultiSite recombination cloning
A schematic diagram outlining the steps involved in two-
fragment Gateway MultiSite cloning is shown in Figure 1B. As
mentioned above, a major aim of this work was to generate a set of
Gateway MultiSite entry clones that would be generally useful to a
wide variety of researchers. For two-fragment MultiSite these
entry clones include pENTR L5-GAL4-L2 and pENTR L5-QF-
L2 for producing constructs with regulatory DNA upstream of
GAL4 and QF, and pENTR L1-20XUAS-R5 and pENTR L1-
5XQUAS-R5 for expressing genes of interest under UAS and
QUAS control. The complete list of pENTR L1-R5 and pENTR
L5-L2 entry clones, as well as all other entry clones described
herein, is presented in Table 1 along with insert sizes, number of
clones screened, and correct clones recovered for each.
To evaluate the functionality of the pENTR L5-GAL4-L2 and
pENTR L5-QF-L2 entry clones we generated pENTR L1-iav-
59Reg-R5 that contains presumptive regulatory DNA immediately
upstream of the predicted translation start site of the trp ion
channel family member iav (we use the designations 59Reg and
39Reg in entry clones to refer to presumptive regulatory DNA
sequences upstream and downstream, respectively, of the
translation start site of the gene from which they originate to
distinguish them from entry clones containing protein coding
sequences). pENTR L1-iav-59Reg-R5 was combined with both
pENTR L5-GAL4-L2 and pENTR L5-QF-L2 in separate LR
reactions with pDESThaw to generate iav-GAL4 and iav-QF.
These expression clones, as well as all other expression clones
described herein, are listed in Table 2 along with total construct
sizes, number of clones screened, correct clones recovered, and
landing sites of the corresponding fly stocks. Confocal images of
iav-GAL4 driving the 20XUAS-CD8GFP reporter and iav-QF
driving the QUAS-mtdTOM-3XHA reporter in third instar larva
are presented in Figures 2A and 2B, respectively. As shown in the
figures, the iav-GAL4 and iav-QF drivers exhibited a chordotonal
organ-specific expression pattern consistent with the known
expression of iav and it’s heterodimer partner nan [6]. The
patterns of expression are not identical, however, as iav-QF does
not express in the lch1 chordotonal organ and variably expresses
in the vch1 and vch2 chordotonal organs. Since the identical iav
Figure 1. Drosophila destination vector and two-fragment
schematic for Gateway MultiSite cloning. A) The Drosophila
destination vector pDESThaw. This destination vector contains an hsp70
polyadenylation sequence, a PhiC31 attB site for PhiC31 integrase-
mediate site-specific transgenesis, and mini-white as a transformation
marker. Appropriate combinations of two, three, or four entry clones
recombine in a position and orientation-specific manner with
ampicillin-resistant pDESThaw in the LR reaction to generate expression
clones. The LR reactions for two, three, and four fragment Gateway
MultiSite recombination all use the LR Clonase II Plus enzyme mix. Both
the BP and LR reactions take advantage of the Gateway cassette that
includes a chloramphenicol resistance marker and the ccdB gene. The
Gateway cassette is located between the attP sites in the pDONR
vectors (Figure S1) and between the attR1 and attR2 sites of the
pDESThaw destination vector. The ccdB gene is toxic to any bacterial
strain that does not contain a genetic suppressor including most
common laboratory bacterial strains used for cloning such as DH10B
and DH5a. ccdB containing clones were propagated using the now
discontinued bacterial strain DB3.1 that has been replaced by
Invitrogen with strain ccdB Survival 2 T1R. When BP and LR reactions
are transformed into non-ccdB suppressor strains, only bacteria
containing clones in which the Gateway cassette has been recombined
out (and presumably the fragment(s) of interest recombined in) survive
on kanamycin or ampicillin-selective plates. This results in a low
frequency of colonies that do not contain the insert(s) of interest. B)
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explanation for the discrepancy is a position effect associated with
the iav-QF landing site attP154 that is not present with iav-GAL4 at
landing site VK00014. As shown in Figures 2D-F, the chordotonal
organ neurons in which both iav drivers express project to the
lateral regions of the ventral nerve cord (VNC) neuropil (arrows,
Figure 2F).
Since the Q system [7] was developed only recently and no QF
driver exists that expresses throughout the nervous system, we
attempted to develop such a driver using regulatory DNA
immediately upstream of the predicted translation start site of
synaptojanin (synj), a gene that functions in synaptic vesicle recycling
[8]. To do this, we first generated pENTR L1-synj-59Reg-R5 and
subsequently used it to create synj-QF in an LR reaction with
pENTR L5-QF-L2 and pDESThaw. synj-QF exhibits broad
expression in the nervous system (Figure 2G), as expected, but
also expresses strongly in imaginal discs (eye disc, arrow
Figure 2G), and at moderate levels in at least the salivary gland
and gut (not shown). Expression of synj-QF in non-neural tissues
was not expected given neuropil-specific expression of Synj in
larva has been previously reported [9]. Explanations for the
discrepancy include the possibility that not all the synj regulatory
region is included in the synj-QF construct or there is a position
effect associated with the attP40 insertion site.
To assess the functionality of pENTR L1-20XUAS-R5 and
pENTR L1-5XQUAS-R5 we generated pENTR L5-CHETA-
YFP-L2 and pENTR L5-eNpHR3.0-YFP-L2. These entry clones
contain the excitatory blue light-activated sodium channel
CHETA-YFP [10] and the inhibitory yellow light-activated
chloride channel eNpHR3.0-YFP [11] that enable optical
excitation and inhibition of neuronal activity, respectively. We
subsequently used these in LR reactions with pDESThaw in all
four combinations to generate 20XUAS-CHETA-YFP, 20XUAS-
eNpHR3.0-YFP, 5XQUAS-CHETA-YFP, and 5XQUAS-eNpHR3.0-
YFP. The expression patterns of these constructs in third instar
larval ventral nerve cords using the synj-QF and scratch-GAL4
drivers, which both express broadly in the larval nervous system,
are shown in Figures 2H-K. All four constructs exhibit broad
expression in the VNC, as expected, and both CHETA-YFP and
eNpHR3.0-YFP distribute relatively evenly between the cell
bodies and axo-dendritic neuropil.
Three-fragment Gateway MultiSite recombination
cloning
A schematic diagram outlining the steps involved in three-
fragment Gateway MultiSite cloning is shown in Figure 3. The
entry clones generated for three-fragment MultiSite cloning
expected to be of general use include pENTR R4-GAL4-R3,
pENTR R4-QF-R3, pENTR L1-20XUAS-L4, pENTR L1-
5XQUAS-L4, pENTR R4-mCherry-R3, pENTR R4-eGFP-R3,
pENTR L3-mCherry-HA-L2, and pENTR L3-eGFP-Myc-L2.
To evaluate the functionality of pENTR R4-GAL4-R3 and
pENTR R4-QF-R3 we generated entry clones containing regulatory
DNA both upstream and downstream of the predicted translation
start sites of several genes including trpA1, nompC, trp,a n dtrpl.T h e s e
include pENTR L1-trpA1-59Reg-L4, pENTR L3-trpA1-39Reg-L2,
pENTR L1-nompC-59Reg-L4, pENTR L3-nompC-39Reg-L2, pENTR
L1-trp-59Reg-L4, pENTR L3-trp-39Reg-L2, pENTR L1-trpl-59Reg-
L4, and pENTR L3-trpl-39Reg-L2. These were used in the LR
reactions with pDESThaw, pENTR R4-GAL4-R3 and pENTR-R4-
Q F - R 3t og e n e r a t etrpA1-GAL4 (trpA1-59Reg-GAL4-trpA1-39Reg),
trpA1-QF (trpA1-59Reg-QF-trpA1-39Reg), nompC-GAL4 (nompC-59Reg-
GAL4-nompC-39Reg), nompC-QF (nompC-59Reg-QF-nompC-39Reg),





screened Insert size (bp)
L1-iav-5’Reg-R5 1 1 596
L1-syjn-5’Reg-R5 5 10 3457
L1-20XUAS-R5 2 2 768
L1-5XQUAS-R5 2 2 438
L1-mCherry-T-R5 1 1 729
L1-eGFP-T-R5 1 1 738
L5-GAL4-L2 1 1 2650
L5-QF-L2 2 2 2455
L5-CHETA-YFP-L2 3 3 2289
L5-eNpHR3.0-YFP-L2 3 4 2310
L1-trpA1-5’Reg-L4 1 1 1773
L1-nompC-5’Reg-L4 1 3 4080
L1-trpL-5’Reg-L4 9 22 5968
L1-trp-5’Reg-L4 3 4 1700
L1-5XQUAS-L4 2 2 438
L1-20XUAS-L4 1 2 768
R4-GAL4-R3 1 1 2650
R4-QF-R3 2 2 2455
R4-mCherry-R3 2 2 712
R4-eGFP-R3 2 2 721
R4-n-syb-R3 3 3 547
R4-CD4-R3 3 3 1378
R4-mCherry-R3 1 1 717
R4-eGFP-T-R3 1 1 726
L3-trpA1-3’Reg-L2 1 1 3455
L3-nompC-3’Reg-L2 1 7 5143
L3-trpL-3’Reg-L2 1 1 2397
L3-trp-3’Reg-L2 1 1 2381
L3-mCherry-HA-L2 1 1 747
L3-eGFP-Myc-L2 1 1 759
L3-Rab3-L2 2 3 660
L5-mCherry-T-L4 1 1 717
L5-eGFP-T-L4 1 1 726
Totals 63 93
L3-4X-mCherry-HA-L2 1 32 2910
L3-4X-eGFP-Myc-L2 3 128 2949
doi:10.1371/journal.pone.0024531.t001
Schematic diagram of two-fragment Gateway MultiSite recombination
cloning. Fragment 1 and fragment 2 are amplified by PCR using
oligonucleotides that incorporate flanking attB1 and attB5r sites in
fragment 1 and flanking attB5 and attB2 sites in fragment 2. Fragment 1
is combined with pDONR 221 P1-P5r and fragment 2 is combined with
pDONR 221 P5-P2 in separate BP reactions. The products of the BP
reactions are pENTR attL1-Frag1-attR5 and pENTR attL5-Frag2-attL2. In
the LR reaction both of these entry clones are combined with a
destination vector to produce an expression clone containing fragment
1 and fragment 2 in a position and orientation-specific manner. Note
that pENTR L1-R5 entry clones are also used in four-fragment Gateway
MultiSite cloning. Schematic modified from the Invitrogen MultiSite
Gateway Pro user manual.
doi:10.1371/journal.pone.0024531.g001
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trp-39Reg).
The trpA1-QF driver exhibited expression in what appeared to be
class IV larval sensory neurons based on their dendritic branching
complexity [12,13]. To determine if this was indeed the case, we
coexpressed trpA1-QF with the class IV sensory neuron-specific
driver ppk-GAL4 and observed their expression using the UAS-
mCD8GFP and QUAS-mtdTOM-3XHA reporters. As shown in
Figures 4A-F, expression of trpA1-QF overlaps that of ppk-GAL4,
thus confirming trpA1-QF expression in class IV larval sensory
neurons. This expression pattern for trpA1-QF is consistent with
expectations since trpA1 has been previously shown to function in
class IV larval sensory neurons as part of a photosensory pathway
[14]. trpA1-GAL4 expression is nearly indistinguishable from that of
trpA1-QF as shown in Figures 4G-L. Both drivers express in the class
IV larval sensory neurons vdaB, vdaa, and ddaC as well as the
external sensory neuron vp5 as indicated in Figure 4G. Although
the dendrites of the trpA1 sensory neurons are distributed broadly
across the larval body wall they project to a discrete region near the
center of the VNC (arrow, Figure 4L). This anatomical arrange-
ment is reminiscent of broadly distributed olfactory neurons in adult
flies [15] and mice [16] that sense the same odorant and project to
the same glomerulus.
The nompC-GAL4 and nompC-QF drivers also express in a
subset of larval sensory neurons. As shown in Figure 5A, nompC-
GAL4 expresses in the chordotonal organs vchA, vchB, lch5, and
lch1, the class III sensory neurons vdaD, v9pda, ldaB, ddaA, and
ddaF, and the dmd1 sensory neuron. The dorsal sensory neuron
cluster from A) was double-labeled with anti-HRP and imaged
at higher magnification and lower signal intensity to allow
the cell body of each individual neuron to be distinguished
(Figures 5B-D). As shown in Figures 5E-G, nompC-QF expression
closely resembles that of nompC-GAL4.T h enompC-GAL4 and
nompC-QF neurons both project to the lateral regions of the
VNC as shown in Figures 5H-J. That these drivers express in
sensory neurons is not surprising given nompC is a mechanore-
ceptor known to function in sensory perception [17,18]. Not
unlike the class IV neurons, the class III and chordotonal organ
neurons are broadly distributed across the larval body wall, but
project to discrete regions of the VNC (different from class IV
neurons). These observations suggest a consolidation of sensory
information type in second-order neurons, again, similar to
previous observations in the olfactory neurons of the adult fly
and mice.
The trpl-QF driver exhibits expression in neurons at the anterior
end of the larva whose cell bodies reside adjacent to the larval
mouth hooks. These neurons seemed most likely to be the
photosensitive Bolwig’s organ neurons both because of their
anatomical location and also because it would not be surprising if
trpl functioned in larval phototransduction since its function in
adult phototransduction is well established [19]. To determine if
the neurons in which trpl-QF expresses are Bolwig’s organ
photoreceptors, it was co-expressed with the Bolwig’s organ driver
Rh6-GAL4 and both were visualized using the 20XUAS-mCD8GFP
and QUAS-mtdTOM-3XHA reporters. As shown in Figures 6A-C,
trpl-QF expression overlaps with Rh6-GAL4 expression in Bolwig’s
organ neurons (arrows, Figure 6C) whose projections terminate
near the center of the larval brain hemispheres (arrowheads,
Figure6C). The trpl-QF driver also exhibits expression in the eye
imaginal disc (arrows, Figure 6B).
Table 2. Expression Clones/Fly stocks.
Construct/stock Correct clones Clones screened Construct size (kb) Insertion site(s)
trpA1-GAL4 34 1 6 VK0014/43A
trpA1-QF 2 3 15.8 attP40/25C; attP154/97D
nompC-GAL4 1 4 19.9 VK0014/43A; attP154/97D
nompC-QF 2 10 19.7 attP40/25C; attP154/97D
iav-GAL4 2 2 11.4 VK00014/43A
iav-QF 2 3 11.2 attP154/97D
trp-GAL4 2 3 14.8 VK00014/43A
trpL-QF 6 6 18.9 attP154/97D
sjn-QF 22 1 4 attP40/25C
20XUAS-CHETA-YFP 1 3 11.2 attP40/25C; attP2/68A
20XUAS-eNpHR3.0-YFP 3 3 11.2 attP40/25C; attP2/68A
QUAS-CHETA-YFP 3 3 10.8 attP33/50B; attP2/68A
QUAS-eNpHR3.0-YFP 2 3 10.8 attP33/50B; attP2/68A
QUAS-mCherry-Rab3 13 9 . 9 attP40/25C; VK00027/89E
QUAS-GFP-Rab3 23 9 . 9 attP40/25C; VK00027/89E
QUAS-N-syb-mCherry-HA 33 9 . 8 attP40/25C
QUAS-N-syb-GFP-Myc 13 9 . 8 attP40/25C
QUAS-N-syb-4XmCherry-HA 2 4 11.9 attP40/25C
QUAS-N-syb-4XGFP-Myc 3 6 11.9 attP40/25C
20XUAS-CD4-4XmCherry-HA 3 3 12.4 attP2/68A
20XUAS-CD4-4XGFP-Myc 3 3 12.4 attP2/68A
Totals 49 77
doi:10.1371/journal.pone.0024531.t002
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determined by its overlapping expression with trpl-QF (Figures 6D-
F) when the two were coexpressed and visualized using the
reporters 20XUAS-mCD8GFP and QUAS-mtdTOM-3XHA. Like trpl,
this is not surprising since the role of trp in adult phototransduction
is also well established [19]. Unlike trpl-QF, expression of trp-GAL4
was not observed in the eye imaginal disc. Surprisingly, trp-GAL4
exhibited its strongest expression in the corpus cardiacum
(arrowhead, Figure 6D), a component of the larval ring gland
that is believed to mediate neuroendocrine functions. Since the
corpus cardiacum is known to function in sensing and regulating
glucose levels in the larva [20], trp expression in this region of the
ring gland raises the intriguing possibility that trp has been co-
opted by the corpus cardiacum to transduce signals associated with
glucose sensing in larva, not unlike its established role of
tranducing signals in adult flies associated with photoreception
(or vice versa, depending on which role came first evolutionarily).
To evaluate the functionality of pENTR L1-5XQUAS-L4, R4-
mCherry-R3, R4-GFP-R3, L3-mCherry-HA-L2, and L3-GFP-
Myc-L2, we decided to attempt to generate red and green
fluorescent synaptic vesicle (SV) markers for the Q system since no
SV markers for it currently exist. The approach we took was to
fuse the fluorescent proteins to the synaptic vesicle membrane-
associated proteins Rab3 and neuronal-synaptobrevin (n-syb) and
Figure 2. Expression of drivers and reporters generated using two-fragment Gateway MultiSite cloning. A-F) Representative confocal
images of yw; iav-GAL4/QUAS-mtdTOM-3XHA; iav-QF/20XUAS-mCD8GFP third instar larval body wall segment (A-C) and ventral nerve cord (D-F)
double-labeled with anti-GFP and anti-HA. iav-GAL4 expresses in the chordotonal organs vchA, vchB, lch5, and lch1. iav-QF expresses in lch5, variably
in vchA and vchB, but not in lch1. The chordotonal organ neurons of both drivers project to the lateral regions of the ventral nerve cord neuropil
(arrows, F). G) Representative confocal image of yw; synj-QF/+; QUAS-mtdTOM-3XHA/+ third instar larva labeled with anti-HA. synj-QF exhibits broad
expression in the nervous system, but also shows strong expression in the imaginal discs (arrow, eye-antennal disc), and moderate expression in at
least the salivary gland and gut (not shown). H-K) Representative confocal images of yw; synj-QF/5XQUAS-CHETA-YFP (H), yw; synj-QF/5XQUAS-
eNpHR3.0-YFP (I), yw; scratch-GAL4/20XUAS-CHETA-YFP (J), and yw; scratch-GAL4/20XUAS-eNpHR3.0-YFP (K) third instar larval ventral nerve cords
labeled with anti-GFP. Each combination exhibits broad expression in the ventral nerve cord with subcellular localization observed in the cell bodies
and the axo-dendritic neuropil. Scale bars: C) 500 mm, F)100 mm, G) 150 mm, H) 75 mm.
doi:10.1371/journal.pone.0024531.g002
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entry clones pENTR L3-Rab3-L2 and pENTR R4-n-syb-R3
which contain the protein coding sequences of Drosophila Rab3 and
n-syb [21]. We combined these entry clones in the LR reaction
with pDESThaw in various combinations to generate 5XQUAS-
eGFP-Rab3, 5XQUAS-mCherry-Rab3, 5XQUAS-n-syb-eGFP-Myc,
and 5XQUAS-n-syb-mCherry-HA.
To assess expression and localization of 5XQUAS-GFP-Rab3 it
was co-expressed with the UAS-mCD8.ChRFP reporter using the
nompC-QF and nompC-GAL4 drivers described above. As shown in
Figure 7A, GFP-Rab3 localization was only detectable in the
region of the VNC where the nompC neuron presynaptic terminals
are located (arrowheads). In contrast, as shown in Figure 7B,
mCD8.ChRFP distribution was observed throughout the nompC
neurons including the cell bodies (large arrow), axons (small
arrow), and presynaptic terminals (arrowheads). Higher resolution
views of the VNC region are shown in Figures 7D-F. A similar
experiment was performed using 5XQUAS-mCherry-Rab3 and
20XUAS-mCD8GFP except observation was via direct fluorescence
and similar results were obtained (data not shown). Restricted
localization of both GFP-Rab3 and mCherry-Rab3 to the
presynaptic terminal regions of nompC neurons indicates both
5XQUAS-eGFP-Rab3 and 5XQUAS-mCherry-Rab3 are reliable SV
reporters for the Q system. Similar constructs were made with
fusions of eGFP and mCherry to the carboxy-terminus of Rab3,
but these were weakly expressed and did not localize to
presynaptic terminals (data not shown). This result indicates
Rab3 localization to SVs will not tolerate carboxy-terminal fusions
of these fluorescent proteins.
The expression and localization of 5XQUAS-n-syb-mCherry-HA
and 5XQUAS-n-syb-GFP-Myc was assessed by co-expression with
UAS-n-syb-GFP and UAS-mCD8.ChRFP, respectively, also using the
nompC-QF and nompC-GAL4 drivers described above. Similar to
GFP and mCherry-tagged Rab3, n-syb-mCherry-HA and n-syb-
GFP-Myc were not detectable anywhere in the nompC neurons
except the presynaptic terminal regions as shown in Figures 8A-C,
G-I. These observations indicate both 5XQUAS-n-syb-mCherry-HA
and 5XQUAS-n-syb-GFP-Myc are also reliable SV reporters for the
Q system. Although n-syb-mCherry-HA was detected with the
anti-HA antibody 3F10 (Roche), we were unable to detect n-syb-
eGFP-Myc with any of three anti-Myc antibodies (9E10-
Developmental Studies Hybridoma Bank; 4A6-Millipore; 289-
19510-Invitrogen/Molecular Probes) even though all three
successfully labeled a different positive control myc-tagged protein
in larval immunohistochemistry (data not shown). This suggests
the myc-tag epitopes recognized by these antibodies are not
accessible, but it does not preclude the possibility that this will be
the case for all anti-myc antibodies.
Although no expression of any of the SV markers was observed
outside the presynaptic terminal regions of nompC neurons, their
expression did not extend as far medially as the other reporters
(Figures 7C,F and 8C,I). One potential reason for this is a position
effect of the nompC-QF driver at landing site attP154. To test this
possibility, the same nompC-QF construct was inserted at landing
site attP40 and used to express the same 5XQUAS-GFP-Rab3 as
before inserted at the attP40 landing site. As shown in Figure 7G,
expression is observed in the more medially projecting nompC
neurons (arrowheads) in this combination, suggesting the lack of
Figure 3. Schematic diagram of three-fragment Gateway MultiSite recombination cloning. Fragments 1, 2, and 3 are amplified by PCR
using oligonucleotides that incorporate flanking attB1 and attB4 sites in fragment 1, flanking attB4r and attB3r sites in fragment 2, and flanking attB3
and attB2 sites in fragment 3. Fragment 1 is combined with pDONR 221 P1-P4, fragment 2 with pDONR 221 P4r-P3r, and fragment 3 with pDONR 221
P2-P2 in separate BP reactions. The products of the BP reactions are pENTR attL1-Frag1-attL4, pENTR attR4-Frag2-attR3, and pENTR attL3-Frag3-attL2.
In the LR reaction these three entry clones are combined with a destination vector to produce an expression clone containing fragment 1, fragment
2, and fragment 3 in a position and orientation-specific manner. Note that the pENTR R4-R3 and pENTR L3-L2 entry clones are also used in four-
fragment Gateway MultiSite recombination cloning. Schematic modified from the Invitrogen MultiSite Gateway Pro user manual.
doi:10.1371/journal.pone.0024531.g003
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attP154 is due to a position effect.
Expression of 5XQUAS-GFP-Rab3 was also examined using the
synj-QF driver described above. The results of co-expression with
QUAS-mtdTOM-3XHA are shown in Figures 9A-C. The majority
of GFP-Rab3 localizes to the neuropil region (arrows, A) where
synaptic vesicles are located. In contrast, expression of mtdTOM-
3XHA is observed not just in the neuropil, but also in the nerves
containing axons and dendrites (arrow, B). In these larvae, low
levels of GFP-Rab3 were detected in the cell bodies of VNC
neurons (arrowheads, A). This is probably due to higher levels of
expression of GFP-Rab3 per neuron using synj-QF as compared to
nompC-QF such that the higher levels of expression with synj-QF has
slightly exceeded the capacity of the cellular machinery to localize
GFP-Rab3 to synaptic vesicles. Thus, expressing these SV
reporters at high levels may reduce their reliability as SV reporters.
Four-fragment Gateway MultiSite recombination cloning
A schematic diagram of four-fragment Gateway MultiSite
recombination cloning is shown in Figure 10. While there is no
overlap in the usage of entry clones between two and three-
fragment Gateway MultiSite cloning, the pENTR L1-R5 (first
position, two-fragment cloning), pENTR R4-R3 (second position,
three-fragment cloning), and pENTR L3-L2 (third position, three-
fragment cloning) entry clones listed in Table 1 can also be used in
four-fragment cloning.
To test the functionality of four-fragment Gateway MultiSite
recombination cloning we made constructs containing four
tandem copies of either eGFP or mCherry. This required the
generation of the entry clones pENTR L1-eGFP-T-R5, pENTR
L5-eGFP-T-L4, and pENTR R4-eGFP-T-R3 and the analogous
entry clones for mCherry (T is for tandem to distinguish their
intended purpose). These entry clones contain neither start nor
stop codons and were used in appropriate combinations with
pENTR L3-eGFP-Myc-L2 and pENTR L3-mCherry-HA-L2
(described above) and pDESThaw to generate 4X-GFP-Myc
and 4X-mCherry-HA. These constructs are not functional in
isolation, since, in addition to the absence of start codons, they
have no upstream UAS or QUAS regulatory regions. Our
intention with them was to use them as PCR templates and
incorporate them into pENTR L3-L2 entry clones containing four
tandem repeats of either eGFP or mCherry that could then be
used in subsequent LR reactions. The difficulty in generating these
entry clones was that in the second round BP reactions there were
two competing attB3 sites: an internal attB3 site (a product of the
first round LR reaction) and the flanking attB3 site. We recovered
colonies utilizing the desired flanking attB3 site (and thus
containing all four tandem repeats of GFP or mCherry) at a
frequency of approximately one in 40 relative to utilization of the
internal attB3 site as indicated at the bottom of Table 1.
The L3-4XmCherry-HA-L2 and L3-4XeGFP-Myc-L2 entry
clones were then used in combination with pENTR L1-5XQUAS-
L4 and pENTR R4-n-syb-R3 to generate 5XQUAS-n-syb-4XGFP-
Myc and 5XQUAS-n-syb-4XmCherry-HA. Expression of 5XQUAS-n-
syb-4XmCherry-HA and 5XQUAS-n-syb-4XGFP-Myc were compared
Figure 4. The trpA1-GAL4 and trpA1-QF drivers express in type IV larval sensory neurons. A-F) Representative confocal images of yw; ppk-
GAL4, UAS-mCD8GFP/QUAS-mtdTOM-3XHA; trpA1-QF/+ third instar larva. trpA1-QF exhibits overlapping expression with the class IV sensory neuron-
specific driver ppk-GAL4 (A-C). ppk-GAL4 and trpA1-QF neurons project to the central region of the VNC (D-F; arrow, F). G-L) Representative confocal
images of a yw; trpA1-GAL4/QUAS-mtdTOM-3XHA; trpA1-QF/20XUAS-mCD8GFP larva. trpA1-GAL4 and trpA1-QF exhibit nearly indistinguishable patterns
of expression in the three class IV neurons vdaB, v9ada, and ddaC and the external sensory organ neuron vp5 (G-I, arrow, G). trpA1-GAL4 and trpA1-QF
both project to the central region of the VNC (J-L, arrow, L). Both animals were double-labeled with anti-GFP and anti-HA. Scale bars: C) and I)
350 mm, F) and L) 100 mm.
doi:10.1371/journal.pone.0024531.g004
Figure 5. The nompC-GAL4 and nompC-QF drivers express in
chordotonal organs and class III larval sensory neurons. A)
Representative composite confocal image of a yw; nompC-GAL4/+;
20XUAS-mCD8GFP/+ third instar larva abdominal body wall segment
labeled with anti-GFP. nompC-GAL4 expresses in the chordotonal
organs vchA, vchB, lch1 and lch5, the class III sensory neurons vdaD,
v9pda, ldaB, ddaA, and ddaF, and the md neuron dmd1. B-D) Higher
resolution confocal images of the dorsal cluster of sensory neurons
from A) labeled with anti-GFP and anti-HRP. Expression of nompC-GAL4
can be distinguished in ddaF, dmd1, and ddaA. E-J) Representative
confocal images of a yw; nompC-GAL4/QUAS-mtdTOM-3XHA; nompC-QF/
20XUAS-CD8GFP third instar larval body wall segment (E-G) and VNC (H-
I) double labeled with anti-GFP and anti-HA. The nompC-QF expression
pattern is very similar to nompC-GAL4. nompC sensory neurons project
to the lateral regions of the VNC (arrows, J). A small number of
presumptive interneurons with cell bodies in the VNC exhibit weak
expression with nompC-GAL4 (arrowheads, H). Scale bars: A) 500 mm, G)
350 mm, J) 100 mm.
doi:10.1371/journal.pone.0024531.g005
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nompC-QF and nompC-GAL4. As shown in Figures 8D-F, J-L, n-
syb-4XmCherry-HA (Figure 8E) shows a nearly indistinguishable
distribution pattern from n-syb-mCherry-HA (Figure 8B). Simi-
larly, n-syb-4XeGFP-Myc (Figure 8J) exhibits a nearly indistin-
guishable distribution pattern from n-syb-eGFP-Myc (Figure 8G).
These results indicate that having four tandem copies of either
eGFP or mCherry fused to the carboxy-terminus of n-syb does not
alter its SV localization as compared to fusion of a single copy of
eGFP or mCherry. However, whether this will be the case for
other proteins can only be determined empirically.
To determine if there were differences in fluorescence intensity
between n-syb fused to one vs four copies of mCherry or eGFP,
direct fluorescence images of age-matched third instar larva
containing n-syb fused to one or four copies of mCherry or eGFP
under QUAS control and expressed using the same nompC-QF
driver were acquired using identical microscope settings between
comparison genotypes. Representative, unmodified confocal
images of third instar larval VNCs are shown in Figures S2A-D.
Quantification revealed 3.5X +/- 0.73 (std dev; n=3) higher
fluorescence intensity for n-syb fused to four copies of mCherry as
compared to one, and 4.4X +/- 1.9 (std dev; n=3) higher
fluorescence intensity for n-syb fused to four copies of eGFP as
compared to one. Both of these values are consistent with the 4X
expectation. That all four copies of mCherry are translated in n-
syb-4XmCherry-HA was demonstrated by its detection of the HA
epitope tag at its carboxy-terminus with an anti-HA antibody and
an Alexa488 coupled secondary antibody whose green fluorescent
signal could not be mistaken for direct mCherry fluorescence (data
not shown). Similar to n-syb-eGFP-Myc, n-syb-4XeGFP-Myc was
not detected with any of the three anti-Myc antibodies mentioned
above, so it was not possible to confirm all four copies of eGFP are
translated using this approach, but the 4.4X higher fluorescence
intensity supports this conclusion.
Given our success in fusing four tandem repeats of the mCherry
and eGFP fluorescent proteins to the synaptic vesicle-specific
protein n-syb and getting the expected ,4X increase in fluo-
rescence intensity without altering its synaptic vesicle localization
suggests this might be a general strategy for increasing the
fluorescence signal of other subcellular markers. This could be
particularly useful in cases where it is not feasible to boost the
fluorescence signal of a fluorescence-tagged subcellular marker by
further increasing the expression level of the protein because the
capacity of the cell to properly localize the protein to its subcellular
compartment has already reached saturation and further increases
in expression would compromise the reliability of the marker. By
Figure 6. The trpl-QF and trp-GAL4 drivers express in Bolwig’s organ larval photoreceptors. A-C) Representative confocal images of a yw;
trpl-QF/20XUAS-mCD8GFP; Rh6-GAL4/ QUAS-mtdTOM-3XHA third instar larva. trpl-QF exhibits overlapping expression with Rh6-GAL4 in Bolwig’s organ.
Bolwig’s organ photoreceptor cell bodies are indicated (arrows, C). These photoreceptor neurons project to the central region of the larval brain
hemispheres (arrowheads, C). In addition, trpl-QF expresses in the eye imaginal disc (arrows, B). D-F) Representative confocal images of a yw; trp-
GAL4/QUAS-mtdTOM-3XHA; trpl-QF/20XUAS-mCD8GFP third instar larva. trp-GAL4 exhibits overlapping expression with trpl-QF in Bolwig’s organ
photoreceptors (arrows, F). trp-GAL4 also exhibits strong expression in the corpus cardiacum region of the ring gland (arrowhead, D). Both images
were double-labeled with anti-GFP and anti-HA. Bo-Bolwig’s organ; cc-corpus cardiacum; ed-eye imaginal disc. Scale bar: 350 mm.
doi:10.1371/journal.pone.0024531.g006
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PLoS ONE | www.plosone.org 9 September 2011 | Volume 6 | Issue 9 | e24531Figure 7. 5XQUAS-GFP-Rab3 is a green fluorescent reporter of synaptic vesicles for the Q system. A-F) Representative confocal images of a
yw; nompC-GAL4/5XQUAS-GFP-Rab3 (attP40); nompC-QF (attP154)/UAS-mCD8.ChRFP third instar larva double-labeled with anti-GFP and anti-CD8.
mCD8.ChRFP localizes to the cell body (large arrow, B), axon (small arrow, B), and lateral neuropil (arrowheads, B) regions of nompC neurons. GFP-
A Gateway MultiSite Recombination Cloning Toolkit
PLoS ONE | www.plosone.org 10 September 2011 | Volume 6 | Issue 9 | e24531fusing tandem repeats of fluorescent proteins to subcellular marker
proteins, the quantity of fluorescence per protein molecule can be
increased (apparently linearly in our example), and thus the
reliable range of subcellular marker fluorescence signal can be
increased beyond what would be possible with fusion of a single
fluorescent protein to a given subcellular marker.
To test the functionality of pENTR L1-20XUAS-L4, the entry
clone pENTR R4-hCD4-R3 (containing full-length human CD4)
was generated and used with pENTR L3-4XmCherry-HA-L2 and
pDESThaw in an LR reaction to produce the expression clone
20XUAS-hCD4-4XmCherry-HA. Since CD4, like CD8, is a
transmembrane protein, it was hoped that this construct would
distribute throughout the plasma membrane of any cell expressing it
and thus provide an alternative reporter of cell morphology of similar
utility as the widely used mCD8GFP. nompC-GAL4 was used to co-
express 20XUAS-hCD4-4XmCherry-HA and 20XUAS-mCD8GFP in
third instar larva and the results are shown in Figures 11A-F. In
Figure 11A, mCD8GFP localizes to cell bodies (large arrowhead),
axons (arrow), and the lateral neuropil (small arrowheads) as
previously observed. In contrast, hCD4-4XmCherry-HA is barely
visible in cell bodies or axons, but exhibits a marked preference for
presynaptic terminals. Higher magnification images of the VNC are
shown in Figures 11D-F. Similar results were obtained with hCD4-
mCherry-HA containing only a single copy of mCherry (data not
shown). Since hCD4-4XmCherry-HA does not distribute to the
plasma membrane with the same uniformity as mCD8GFP, it may
therefore be of limited use, but the functionality of pENTR L1-
20XUAS-L4 is nevertheless demonstrated.
Discussion
In this report we presented and verified the functionality of a
collection of entry clones and a Drosophila destination vector for
Gateway MultiSite recombination cloning. This modular toolkit
enhances the efficiency and flexibility with which DNA constructs
can be generated and it therefore represents a significant advance
over Gateway single-fragment cloning, and an even greater
advance over traditional restriction enzyme-based cloning. The
series of entry clones we developed can be used in two, three, and
four fragment MultiSite cloning to produce a wide variety of
expression constructs as we have demonstrated in Drosophila. They
can, however, potentially be utilized in other model systems
pending only the development of suitable destination vectors.
Advantages of Gateway MultiSite cloning
Single-fragment Gateway cloning is advantageous over tradi-
tional restriction enzyme-based cloning because the frequency of
background colonies containing incorrect clones is sharply lower,
the recombination reactions are more efficient and reliable than
ligations, and internal recombinase recognition sequences are
essentially nonexistent (and therefore don’t have to be considered
on a case-by-case basis in cloning strategies). Thus, single-fragment
Gateway cloning results in an increase in cloning efficiency in
certain instances and is especially suitable for high-throughput,
repetitive cloning applications.
However, single-fragment Gateway cloning has the disadvan-
tage that destination vectors are difficult to construct. They are
typically generated using traditional restriction enzyme cloning,
entail multiple cloning steps, and require a special bacterial strain
that suppresses the lethality of the ccdB gene in the Gateway
cassette. Thus, the decision to use traditional restriction enzyme
cloning or Gateway cloning usually hinges on the expected
frequency of use of the destination vector. For many individual
labs not engaged in highly repetitive genome scale projects, it is
thus often not worth the up-front time investment to generate
destination vectors if they will only be used once or infrequently.
Hence, the majority of cloning is still restriction enzyme-based.
The Gateway MultiSite cloning toolkit presented here has the same
advantages mentioned above over restriction enzyme-based cloning as
single-fragment Gateway cloning,but it does not have the disadvantage
that it requires the construction of large numbers of destination vec-
tors. In Gateway single-fragment cloning, most variations, such as
fluorescent or epitope tags, etc., are incorporated in destination vectors.
Hence, single-fragment Gateway cloning systems necessitate the
construction of large numbers of destination vectors incorporating
each novel variation. As examples, 66 destination vectors were
generated in one such Drosophila system [22] and 288 destination
vectors in a yeast system [23]. In contrast, introducing a new variant
into the Gateway MultiSite toolkit described here only requires the
construction of a new entry clone. As already mentioned above,
destination vectors are typically generated through a time-consuming,
multi-step restriction enzyme-based cloning process. Since up to four
DNA fragments can be simultaneously cloned into a destination vector
using Gateway MultiSite recombination cloning, this allows variations
to reside in entry clones that are easily generated in an efficient, single
step process. This is a major advantage over single-fragment Gateway
cloning approaches because it obviates the need to generate large
numbers of destination vectors. Since the up-front investment for using
Gateway MultiSite cloning is thus largely reduced from generating
destination vectors to generating entry clones, this should make it an
appealing alternative to restriction enzyme cloning even for the routine,
non-repetitive day-to-day cloning performed by the vast majority of
research labs. The strategic, modular design of this Gateway MultiSite
toolkit allowed the generation by two, three, and four-fragment
Gateway MultiSite cloning of all of the wide variety of expression
constructs presented using a single destination vector.
Furthermore, since entry clones have the versatility to be used
with any compatible destination vector they eliminate the need to
generate destination vectors for all model systems with a compatible
destination vector. For example, if a brighter, more photostable
version of GFP were developed, to incorporate the new version
using single-fragment Gateway based systems would require the
construction of new destination vectors for each model system. In
contrast, the generation of a single entry clone containing the new
GFP variant would be sufficient to allow any model system with a
compatible destination vector to utilize it.
Limitations of Gateway MultiSite cloning
Gateway MultiSite recombination cloning allows the insertion
of two, three, or four fragments into a destination vector to
Rab3 localization is only observed in the lateral neuropil region of the ventral nerve cord (arrowheads, A) where the presynaptic terminals of nompC
neurons are located. The image in A) was collected at higher than usual signal intensity to detect possible weak signals in the cell body or axonal
regions but none were observed. D-F) Higher magnification images of the ventral nerve cord. G-I) Representative confocal images of a yw; QUAS-
mtdTOM-3XHA/+; nompC-QF (attP154)/5XQUAS-GFP-Rab3 (VK00027) third instar larva ventral nerve cord. The VK00027 insertion site of 5XQUAS-GFP-
Rab3 exhibits increased expression levels relative to attP40 in the more medial portion of the nompC neuron projection region (arrowheads, G). J-L)
Representative confocal images of a yw; nompC-QF (attP40)/5XQUAS-GFP-Rab3 (attP40); QUAS-mtdTOM-3XHA/+ third instar ventral nerve cord. The
attP40 insertion site of nompC-QF exhibits increased expression levels relative to attP154 in the more medial portion of the nompC neuron projection
region (arrowheads, J). The images in G-L were double-labeled with anti-GFP and anti-HA. Scale bar: 100 mm.
doi:10.1371/journal.pone.0024531.g007
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PLoS ONE | www.plosone.org 11 September 2011 | Volume 6 | Issue 9 | e24531Figure 8. Fusion variants of neuronal-synaptobrevin function as red and green fluorescent synaptic vesicle reporters for the Q
system. A-F) Representative confocal images of yw; nompC-GAL4/5XQUAS-n-syb-mCherry-HA; nompC-QF (attP154)/UAS-n-syb-GFP (A-C) and yw;
nompC-GAL4/5XQUAS-n-syb-4XmCherry-HA; nompC-QF (attP154)/UAS-n-syb-GFP (D-F) third instar larval ventral nerve cords double-labeled with anti-
GFP and anti-HA. Expression of n-syb-mCherry-HA and n-syb-4XmCherry-HA is restricted to the lateral regions of the neuropil where nompC neuron
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a broad range of cloning applications, especially if common
elements are strategically integrated into the destination vectors as
was done with the Drosophila destination vector pDESThaw.
However, for some applications insertion of four fragments will not
be sufficient. In these cases, there are several options to overcome
the four-fragment limitation. One option is to fuse fragments
together using hybrid PCR, or other method of fusion such as
Invitrogen’s GENEART or Clonetech’s In-Fusion systems, before
incorporation into entry clones. This option may also be useful if
the linker region between two fragments in the expression clone
cannot be tolerated. If the linker region is not translated this is less
likely to be a problem, but if it is translated as part of a fusion
protein then the potential for intolerance is increased. A second
option is to do sequential Gateway MultiSite cloning such that
products of a first round LR reaction containing multiple elements
are cloned into an entry clone that can then be used in a second
round LR reaction. Although difficult due to the presence of
internal attB sites in the second round BP reaction, this approach
is possible as we demonstrated with the generation of the pENTR
L3-4XeGFP-Myc-L2 and pENTR L3-4XmCherry-HA-L2 entry
clones that contain four tandem copies of GFP or mCherry,
respectively. A third option is to incorporate additional elements
into destination vectors.
What are the size limitations for entry and expression clones
using MultiSite Gateway cloning? The largest fragment we
successfully inserted into an entry clone was 5968bp to create
pENTR L1-trpl-59Reg-L4. We made several attempts to clone
PCR fragments ranging in size from 7–11kb into entry clones
but were not successful even when the BP reactions were
allowed to proceed overnight. These results demonstrate it is
possible to produce entry clones with inserts ,6k bi ns i z e ,b u t
suggests generating entry clones with larger insert sizes will not
be routine.
Five expression clones were generated by the LR reaction that
were over 15 kb in total size with the largest of these being
nompC-GAL4 at 19.9 kb. As noted in the Materials and Methods,
the combined success frequency (percentage of colonies containing
the correct clone) was 51.8% for these five constructs. This
relatively high frequency of recovering correct expression clones in
the 15–20 kb size range suggests the expression clone size limit
using Gateway MultiSite cloning has not been reached. In
instances where the LR reactions failed to produce the correct
expression clone with high frequency, it was typically due to
degraded or poorly quantitated input DNAs and repeats of the LR
reactions using fresh DNA preps were usually successful.
While Gateway MultiSite cloning has several advantages over
restriction enzyme cloning as discussed above, cost must also be a
consideration. Unfortunately, the initial cost of the Gateway
MultiSite kit containing the six essential pDONR vectors is
substantial and will be a factor limiting the adoption of Gateway
MultiSite cloning. However, once the one-time cost of the six
pDONR vectors has been borne the ongoing cost of the BP and LR
enzyme mixes is not that out of line with the cost of restriction
enzymesand ligase,especiallyiftheBPand LRreactionsarecarried
out at half the volumes of that recommended by the manufacturer
as we did. Also, because of the high efficiency of the BP and LR
reactions there is likely to be some cost savings over restriction
enzyme cloning in reagents used for preparation of miniprep DNA
since correct clones are recovered at high frequency.
presynaptic terminals are located. G-L) Representative confocal images of yw; nompC-GAL4/5XQUAS-n-syb-GFP-Myc (G-I) and yw; nompC-QF (attP154)/
UAS-mCD8.ChRFP third instar larval ventral nerve cords double-labeled with anti-GFP and anti-CD8. Expression of n-syb-GFP-Myc and n-syb-4XGFP-
Myc is restricted to the lateral regions of the neuropil where nompC neuron presynaptic terminals are located. Scale bar: 100 mm.
doi:10.1371/journal.pone.0024531.g008
Figure 9. GFP-Rab3 distributes broadly within the larval neuropil when driven by synj-QF. A-C) Representative confocal images of synj-QF/
5XQUAS-GFP-Rab3 (attP40); QUAS-mtdTOM-3XHA/+ third instar larval ventral nerve cords double-labeled with anti-GFP and anti-HA. GFP-Rab3
localization is highly preferential to the neuropil region of synj-QF neurons (arrows, A) and is broadly distributed within the neuropil similar to
mtdTOM-3XHA. However, a small amount of GFP-Rab3 is detected in the cell bodies (arrowheads, A) that that is probably a result of the high level of
expression of syjn-QF. In contrast to mtdTOM-3XHA that distributes robustly to axons and dendrites within larval nerves (arrow, B), GFP-Rab3 is nearly
undetectable in these regions of larval sensory and motor neurons. Bottom panels are orthogonal views of the images above. White bars in A)
indicate the location from which the orthogonal views were taken. Scale bar: 100 mm.
doi:10.1371/journal.pone.0024531.g009
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This Gateway MultiSite recombination cloning toolkit provides
a basic set of entry clones for potential use in any model system
and a compatible destination vector for Drosophila transgenesis.
The utility of the toolkit will only expand as additional entry clones
and destination vectors become available. To facilitate use of the
toolkit, we have established a website database to inventory entry




PCR was performed using AccuPrime Pfx SuperMix (Invitrogen-
Cat. # 12344-040). The template for all genomic PCR reactions was
genomic DNA isolated from the strain y; cn bw sp [24]. The templates
for protein-coding entry clones were as follows: L5-CHETA-EYFP-
L2)pLenti-CaMKIIa-hChR2(E123T-H134R)-EYFP [10], L5-
eNpHR3.0-EYFP-L2)pLenti-CaMKIIa-eNpHR 3.0-EYFP [11],
L5-QF-L2 and R4-QF-R3)pattB-QF-SV40 [7], L1-5XQUAS-R5
and L1-5XQUAS-L4)pQUAST [7], L1-20XUAS-R5 and R4-
20XUAS-R3)pJFRC7 [25], L5-GAL4-L2 and R4-GAL4-R3)CaS-
peR-AUG-GAL4 [15], L3-Rab3-L2 )Rab3 cDNA (BDGP
LP05860), R4-n-syb-R3) n-syb cDNA [21], R4-CD4-R3)pMX
hCD4 [26], R4-eGFP-R3 L3-eGFP-Myc-L2, L1-eGFP-T-R5, L5-
eGFP-T-L4, and R4-eGFP-T-R3)pEGFP (Clontech Cat# 6077-1),
R4-mCherry-R3, L3-mCherry-HA-L2, L1-mCherry-T-R5, L5-
mCherry-T-L4, and R4-mCherry-T-R3) pmCherry [27] (Clontech
Cat. #-632522). Primer sequences are available upon request. All
entry clones containing protein-coding genes were sequenced to ensure
errors were not introduced by PCR. All entry clones containing
genomic DNA were sequenced on both ends and exhibited the
predicted restriction patterns.
The pDESThaw vector was constructed in four steps. First, a
0.4 kb Nhe I/Asc I PCR fragment containing the PhiC31 attB site
from pBPGUw[4] wasclonedinto the Nhe I/Asc I sitesofpCasPeR5
[28].Second,a0.25 kbXbaI/BamHIPCRfragmentcontainingthe
hsp70polyadenylation sequencefrom pBPGUwwas clonedintothe
Xba I/Bam HI sites of the resulting vector from step 1. Third, the
1.7 kb Gateway cassette RF C.1 (Invitrogen Cat # 11828-029) was
cloned into the Hpa I site of the resulting vector from step two. The
resulting vector from step three we designate pDESThawP. This
vector is a functional destination vector that contains both P-
element ends for P-element-mediated transformation as well as the
PhiC31 attB site for PhiC31 integrase-mediated transformation but it
was not used in this study. Fourth, to eliminate the P-element ends,
Figure 10. Schematic diagram of four-fragment Gateway MultiSite recombination cloning. Fragment 1, fragment 2, fragment 3, and
fragment 4 are amplified by PCR using oligonucleotides that incorporate flanking attB1 and attB5r sites in fragment 1, flanking attB5 and attB4 sites in
fragment 2, flanking attB4r and attB3r sites in fragment 3, and flanking atB3 and attB2 sites in fragment 4. Fragment 1 is combined with pDONR 221
P1-P5r, fragment 2 with pDONR 221 P5-P4, fragment 3 with pDONR 221 P4r-P3r, and fragment 4 with pDONR 221 P3-P2 in separate BP reactions. The
products of the BP reactions are pENTR attL1-Frag1-attR5, pENTR attL5-Frag2-attL4, pENTR attR4-Frag3-attR3, and pENTR attL3-Frag4-attL2. In the LR
reaction these four entry clones are combined with a destination vector to produce an expression clone containing fragment 1, fragment 2, fragment
3, fragment 4 in a position and orientation-specific manner. Note that pENTR L1-R5 entry clones are used in two-fragment and pENTR R4-R3 and
pENTR L3-L2 entry clones in three-fragment Gateway MultiSite recombination cloning. Schematic modified from the Invitrogen MultiSite Gateway Pro
user manual.
doi:10.1371/journal.pone.0024531.g010
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the Pst I/Asc I sites of pBS-C5 [29] to generate pDESThaw which
was used exclusively in this study.
The six pDONR vectors were obtained as part of the MultiSite
Gateway Pro Plus kit (Invitrogen-Cat # 12537-100). All BP
reactions were performed using the BP Clonase II enzyme mix
(Invitrogen-Cat # 11789-020) in 5 ml volumes (half the manufac-
turer’s recommendation) for 1 hr to overnight at room temperature
(Proteinase K digestion omitted), run through a spin column (Zymo
Research Cat # D4104), eluted in 6 ml of water, electroporated
(2 ml) into 50 ml DH10B electrocompetent cells prepared in our
laboratory, and plated on LB kanamycin plates (50 mg/ml).
The LR reactions were performed using the LR Clonase II Plus
enzyme mix (Invitrogen-Cat # 12538-120) in 5 ml volumes (half
the manufacturer’s recommendation) overnight at room temper-
ature (Proteinase K digestion omitted), run through a spin column
(Zymo Research Cat # D4104), eluted in 6 ml of water,
electroporated (2 ml) into 5 ml ElectroMax DH10B electrocompe-
tent cells (one-fourth the manufacturer’s recommendation; In-
vitrogen-Cat # 18290-015) +45 ml ice-cold sterile water, and
plated on LB carbenicillin plates (50 mg/ml).
Quantitative data on the efficiencies of the BP and LR reactions
is shown in Tables 1 and 2, respectively. Overall efficiency
(percent of colonies containing correct clones) for the BP reactions
used to generate 33 of the 35 entry clones described herein was
determined to be 67.7% (63/93) (L3-4X-mCherry-HA-L2 and L3-
4X-eGFP-Myc-L2 were excluded from this calculation because
they were generated in sequential BP reactions that had competing
attB3 sites as described in Results). We also note a size dependency
to the success rate of the BP reactions. For the 28 BP reactions
where the insert size was ,3 kb the success rate was 92% (46/50),
while for the five BP reactions where the insert size was .3 kb the
success rate was 39.5% (17/43). The overall success rate for the 21
LR reactions was determined to be 63.6% (49/77). The success
rate of the LR reactions also decreases with size although it is less
pronounced than for the BP reactions. For the 16 LR reactions
where the total size of the final construct was ,15 kb the success
rate was 70% (35/50), while for the 5 LR reactions where the total
size of the final construct was .15kb it was 51.8% (14/27).
Drosophila stocks. Flies were reared at 25C and raised on
standard cornmeal/molasses food. All transgenic fly strains
presented in this study including insertion sites are listed in
Table 2. Transgenic fly production was performed by Bestgene,
Inc., Chino Hills, CA. Other transgenic fly strains used in this
study with Bloomington stock numbers in parentheses: yw; QUAS-
mtdTomato-3XHA [7] (30004; 30005), w; 20XUAS-IVS-mCD8GFP
[25] (32194), w; ppk-GAL4, UAS-mCD8GFP [13] (8749), yw; Rh6-
GAL4 [29] (7459), w; scratch-GAL4 [30], UAS-mCD8.ChRFP (27391;
27392; F. Schnoorer, unpublished), UAS-n-syb-GFP [31], and
landing site stocks [32,33].
Figure 11. The CD4-4XmCherry-HA reporter preferentially localizes to presynaptic terminals. A-F) Representative confocal images of yw;
nompC-GAL4/20XUAS-hCD4-4XmCherry-HA; 20XUAS-mCD8GFP/+ third instar larva double-labeled with anti-GFP and anti-HA. A-C) mCD8-GFP is easily
visualized in cell bodies (larger arrowhead, A), axons (arrow, A) and presynaptic terminals (smaller arrowheads, A). In contrast, CD4-4X-mCherry-HA (B)
is barely visible in the cell bodies and axons, but exhibits preferential localization to presynaptic terminals (labeling same as in A). D-F) Higher
magnification images of the VNC. Scale bars: C) 350 mm, F) 100 mm.
doi:10.1371/journal.pone.0024531.g011
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coated slides using minuten pins. After dissection, larvae were fixed
in 4% paraformaldehyde for 30 minutes at room temperature and
washed 3X two minutes in PBS. Larvae were then blocked in
PBSTNGS (PBS +2% Triton X-100 +5% normal goat serum) for $
1 hr at room temperature, incubated with primary antibody diluted in
PBSTNGS overnight at 4C, washed 5X two minutes in PBS,
incubated with secondary antibody diluted in PBSTNGS overnight at
4C, washed 5X two minutes in PBS, before imaging on a Leica TCS-
SP confocal microscope. Primary antibodies used in this study were
rabbit anti-GFP Abfinity mAb (Invitrogen-Cat # G10362; 1:200),
mouse anti-GFP mAb3E6 (Invitrogen-Cat # A-11120; 1:200), Rat
anti-HA mAb 3F10 (Roche-Cat # 11 867 423 001; 1:200), and Rat
anti-CD8a (Invitrogen-Cat # MCD0800; 1:100). Secondary
antibodies used in this study were donkey anti-Rabbit DyLight 488
(Jackson Immunoresearch-Cat # 711-485-152; 1:500), goat anti-
Rabbit Alexa Fluor 488 (Invitrogen-Cat # A-11034; 1:500), goat anti-
mouse Alexa Fluor 488 (Invitrogen-Cat # A-11029; 1:500), and goat
anti-rat Alexa Fluor 568 (Invitrogen-Cat # A-11077; 1:500).
Image Quantitation
Images were acquired with a Zeiss Lumar fluorescent stereo-
microscopeequippedwithaQiCamcameraandQCapturesoftware.
Images being compared were acquired using identical microscope
and software settings. Quantification was done on iVision software.
Background levels were subtracted uniformly and equally between
comparison images and ratios of fluorescence intensity were obtained
by dividing the summation of total pixel intensity across the ventral
nerve cord.
Supporting Information
Figure S1 Donor vectors for Gateway MultiSite cloning.
A) The six pDONR vectors from the Gateway MultiSite Pro Plus
kit. All six pDONR vectors are kanamycin resistant and are highly
similar except for their distinct attP sites. The attP-containing
donor vectors are used in the BP reaction with attB flanked DNA
fragments (typically generated by PCR) to create entry clones.
During the BP reaction the attB and attP sites are converted to
attL and attR sites. attP sites of the same color indicate
recombination compatibility of their corresponding attL and attR
sites in the LR reaction. This same color scheme is used in
Figures 1, 3, and 10. The BP reactions for all six donor vectors use
the BP Clonase II enzyme mix.
(TIF)
Figure S2 Four tandem repeats of mCherry or eGFP
fused to n-syb exhibits increased fluorescence intensity
as compared to fusion of one copy. A-D) Representative
confocal images of A) yw; 5XQUAS-n-syb-mCherry-HA/+; nompC-
QF/+;B )yw; 5XQUAS-n-syb-mCherry-HA; nompC-QF/+;C )yw;
5XQUAS-n-syb-eGFP-Myc/+; nompC-QF/+;D )yw; 5XQUAS-n-syb-
4XeGFP-Myc/+; nompC-QF/+ age-matched third instar larva
ventral nerve cords imaged via direct fluorescence. The images
in A) and B) were acquired using identical confocal settings with
568 nm excitation as were the images in C) and D) with 488 nm
excitation. Scale bar: 100 mm.
(TIF)
Table S1 attB primer sequences for Gateway MultiSite cloning. The
attB sequences flank gene-specific sequences in the oligonucleotides
used to generate the PCR products that will be used as substrates in the
BP reaction. Since only specific combinations of attB and attP sites are
functional in the BP reaction, the attB sites must be chosen based on
compatibility with the attP sites of each pDONR vector.
(XLSX)
Acknowledgments
We thank Ehud Isacoff for support and encouragement during the initial
stages of this work and the Bloomington Drosophila Stock Center for fly
strains. Fly stocks will be deposited at the Bloomington Drosophila Stock
Center. Select plasmids will be deposited at Addgene.
Author Contributions
Conceived and designed the experiments: RSS. Performed the experi-
ments: RSS. Analyzed the data: RSS LKP. Contributed reagents/
materials/analysis tools: RSS. Wrote the paper: RSS.
References
1. Hartley JL, Temple GF, Brasch MA (2000) DNA cloning using in vitro site-
specific recombination. Genome Res 10: 1788–95.
2. Gong W, Shen YP, Ma LG, Pan Y, Du YL, et al. (2004) Genome-wide
ORFeome cloning and analysis of Arabidopsis transcription factor genes. Plant
Physiol 125: 773–82.
3. Luan CH, Qiu S, Finley JB, Carson M, Gray RJ, et al. (2004) High-throughput
expression of C. elegans proteins. Genome Res 14: 2101–10.
4. Pfeiffer BD, Jenett A, Hammonds AS, Ngo TT, Misra S, et al. (2008) Tools for
neuroanatomy and neurogenetics in Drosophila. Proc Natl Acad Sci 105: 9715–20.
5. Cheo DL, Titus SA, Byrd DR, Hartley JL, Temple GF, et al. (2004) Concerted
assembly and cloning of multiple DNA segments using in vitro site-specific
recombination: functional analysis of multi-segment expression clones. Genome
Res 14: 2111–20.
6. Gong Z, Son W, Chung YD, Kim J, Shin DW, et al. (2004) Two interdependent
TRPV channel subunits, inactive and Nanchung, mediate hearing in Drosophila.J
Neurosci 24: 9059–66.
7. Potter CJ, Tasic B, Russler EV, Liang L, Luo L (2010) The Q system: a
repressible binary system for transgene expression, lineage tracing, and mosaic
analysis. Cell 141: 536–48.
8. Dickman DK, Horne JA, Meinertzhagen IA, Schwarz TL (2005) A slowed
classical pathway rather than kiss-and-run mediates endocytosis at synapses
lacking synaptojanin and endophilin. Cell 123: 521–33.
9. Verstreken P, Koh TW, Schulze KL, Zhai RG, Hiesinger PR, et al. (2003)
Synaptojanin is recruited by endophilin to promote synaptic vesicle uncoating.
Neuron 40: 733–48.
10. Gunaydin LA, Yizhar O, Berndt A, Sohal VS, Deisseroth K, et al. (2010)
Ultrafast optogenetic control. Nat Neurosci 13: 387–92.
11. Gradinaru V, Zhang F, Ramakrishnan C, Mattis J, Prakash R, et al. (2010)
Molecular and cellular approaches for diversifying and extending optogenetics.
Cell 141: 154–65.
12. Grueber WB, Jan LY, Jan YN (2002) Tiling of the Drosophila epidermis by
multidendritic sensory neurons. Development 129: 2867–78.
13. Grueber WB, Ye B, Yang CH, Younger S, Borden K, et al. (2007) Projections of
Drosophila multidendritic neurons in the central nervous system: links with
peripheral dendrite morphology. Development 134: 55–64.
14. Xiang Y, Yuan Q, Vogt N, Looger LL, Jan LY, et al. (2010) Light-avoidance-
mediating photoreceptors tile the Drosophila larval body wall. Nature 468: 921–6.
15. Vosshall LB, Wong AM, Axel R (2000) An olfactory sensory map in the fly
brain. Cell 102: 147–159.
16. Mombaerts P, Wang F, Dulac C, Chao SK, Nemes A, et al. (1996) Visualizing
an Olfactory Sensory Map. Cell 87: 675–686.
17. Kernan M, Cowan D, Zuker C (1994) Genetic dissection of mechanosensory
transduction: mechanoreception-defective mutations of Drosophila. Neuron 12:
1195–206.
18. Walker RG, Willingham AT, Zuker CS (2000) A Drosophila mechanosensory
transduction channel. Science 287: 2229–34.
19. Montell C (2005) TRP channels in Drosophila photoreceptor cells. J Physiol 567:
45–51.
20. Kim SK, Rulifson EJ (2004) Conserved mechanisms of glucose sensing and
regulation by Drosophila corpora cardiaca cells. Nature 431: 316–20.
21. DiAntonio A, Burgess RW, Chin AC, Deitcher DL, Scheller RH, et al. (1993)
Identification and characterization of Drosophila genes for synaptic vesicle
proteins. J Neurosci 13: 4924–35.
22. Available at: http://www.ciwemb.edu/labs/murphy/Gateway%20vectors.html.
A Gateway MultiSite Recombination Cloning Toolkit
PLoS ONE | www.plosone.org 16 September 2011 | Volume 6 | Issue 9 | e2453123. Alberti S, Gitler AD, Lindquist S (2007) A suite of Gateway cloning vectors
for high-throughput genetic analysis in Saccharomyces cerevisiae.Y e a s t2 4 :
913–9.
24. Adams MD, Celniker SE, Holt RA, Evans CA, Gocayne JD, et al. (2000) The
genome sequence of Drosophila melanogaster. Science 287: 2185–95.
25. Pfeiffer BD, Ngo TT, Hibbard KL, Murphy C, Jenett A, et al. (2010)
Refinement of tools for targeted gene expression in Drosophila. Genetics 186:
735–55.
26. Landau NR, Warton M, Littman DR (1988) The envelope glycoprotein of the
human immunodeficiency virus binds to the immunoglobulin-like domain of
CD4. Nature 334: 159–62.
27. Shaner NC, Campbell RE, Steinbach PA, Giepmans BN, Palmer AE, et al.
(2004) Improved monomeric red, orange and yellow fluorescent proteins derived
from Discosoma sp. red fluorescent protein. Nat Biotechnology 22: 1567–72.
28. Le T, Yu M, Williams B, Goel S, Paul SM, et al. (2007) CaSpeR5, a family of
Drosophila transgenesis and shuttle vectors with improved multiple cloning sites.
Biotechniques 42: 164–66.
29. Tahayato A, Sonneville R, Pichaud F, Wernet MF, Papatsenko D, et al. (2003)
Otd/Crx, a dual regulator for the specification of ommatidia subtypes in the
Drosophila retina. Dev Cell 5(3): 391–402.
30. Hughes CL, Thomas JB (2007) A sensory feedback circuit coordinates muscle
activity in Drosophila. Mol Cell Neurosci 35: 383–96.
31. Zhang YQ, Rodesch CK, Broadie K (2002) Living synaptic vesicle marker:
synaptotagmin-GFP. Genesis 34: 142–5.
32. Markstein M, Pitsouli C, Villalta C, Celniker SE, Perrimon N (2008) Exploiting
position effects and the gypsy retrovirus insulator to engineer precisely expressed
transgenes. Nat Genet 40: 476–83.
33. Venken KJ, He Y, Hoskins RA, Bellen HJ (2006) P[acman]: a BAC transgenic
platform for targeted insertion of large DNA fragments in D. melanogaster. Science
314: 1747–51.
A Gateway MultiSite Recombination Cloning Toolkit
PLoS ONE | www.plosone.org 17 September 2011 | Volume 6 | Issue 9 | e24531